Andere Sprachen GlycoMimetics, Inc.

Aktien

A1W8HZ

US38000Q1022

GLYC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
1.62 ^USD	-10.00%		-12.67%	-31.36%

27.03.	Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
27.03.	GlycoMimetics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024	25.04.
GlycoMimetics: Q4 Earnings Snapshot	27.03.
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023	27.03.
GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
GlycoMimetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27.03.
North American Morning Briefing : Stocks Edge -2-	27.03.
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024	13.03.
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference	26.02.
GlycoMimetics Reports Inducement Grant under NASDAQ Listing Rule 5635(4)	13.02.
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	12.02.
GlycoMimetics, Inc. Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1A Healthy Volunteer Study of GMI-1687	04.01.
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687	04.01.
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	03.01.
GlycoMimetics, Thermo Fisher Unit Set Accord for Manufacturing Uproleselan for Acute Myeloid Leukemia	02.01.
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	10.12.
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference	09.11.
GlycoMimetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03.11.
GlycoMimetics: Q3 Earnings Snapshot	03.11.
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023	03.11.
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	23.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GlycoMimetics, Inc.

Aktien

A1W8HZ

US38000Q1022

GLYC

Andere Sprachen

Filter